Santhera Pharmaceuticals: Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA
Horizon Discovery is a world-leader in the application of gene editing and gene modulation technologies and is at the centre of innovation and drug discovery.
Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.
Consilium Healthcare - RT @DetailJunkie: I look forward to attending the 10th Anniversary CNS Summit in Boca Raton, FL in 10 days! Please feel free to connect and…